Prognostic Significance of Absolute Lymphocyte Count/Absolute Monocyte Count Ratio at Diagnosis in Patients with Multiple Myeloma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Absolute lymphocyte count (ALC) in peripheral blood has recently been reported to be an independent prognostic factor in multiple myeloma (MM). Previous studies indicated that the absolute monocyte count (AMC) in peripheral blood reflects the state of the tumor microenvironment in lymphomas. Neither the utility of the AMC nor its relationship with ALC has been studied in MM. Methods: The prognostic value of ALC, AMC, and the ALC/AMC ratio at the time of diagnosis was retrospectively examined in 189 patients with MM. Results: On univariate analysis, low ALC (<1,400 cells/μL), high AMC (≥490 cells/μL), and low ALC/AMC ratio (<2.9) were correlated with worse overall survival (OS) (p=.002, p=.038, and p=.001, respectively). On multivariate analysis, the ALC/AMC ratio was an independent prognostic factor (p=.047), whereas ALC and AMC were no longer statistical significant. Low ALC, high AMC, and low ALC/AMC ratio were associated with poor prognostic factors such as high International Staging System stage, plasmablastic morphology, hypoalbuminemia, and high β2-microglobulin. Conclusions: Univariate analysis demonstrated that changes in ALC, AMC, and the ALC/AMC ratio are associated with patient survival in MM. Multivariate analysis showed that, of these factors, the ALC/AMC ratio was an independent prognostic factor for OS.
Abstract
Background: Absolute lymphocyte count (ALC) in peripheral blood has recently been reported to be an independent prognostic factor in multiple myeloma (MM). Previous studies indicated that the absolute monocyte count (AMC) in peripheral blood reflects the state of the tumor microenvironment in lymphomas. Neither the utility of the AMC nor its relationship with ALC has been studied in MM. Methods: The prognostic value of ALC, AMC, and the ALC/AMC ratio at the time of diagnosis was retrospectively examined in 189 patients with MM. Results: On univariate analysis, low ALC (<1,400 cells/μL), high AMC (≥490 cells/μL), and low ALC/AMC ratio (<2.9) were correlated with worse overall survival (OS) (p=.002, p=.038, and p=.001, respectively). On multivariate analysis, the ALC/AMC ratio was an independent prognostic factor (p=.047), whereas ALC and AMC were no longer statistical significant. Low ALC, high AMC, and low ALC/AMC ratio were associated with poor prognostic factors such as high International Staging System stage, plasmablastic morphology, hypoalbuminemia, and high β2-microglobulin. Conclusions: Univariate analysis demonstrated that changes in ALC, AMC, and the ALC/AMC ratio are associated with patient survival in MM. Multivariate analysis showed that, of these factors, the ALC/AMC ratio was an independent prognostic factor for OS.
참고문헌 (30)
- Porrata LF, "Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma", Am J Hematol, 84, pp.93~97 (2009)
- Kim H, "Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma", Bone Marrow Transplant, 37, pp.1037~1042 (2006)
- Ege H, "Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study", Br J Haematol, 141, pp.792~798 (2008)
- Podar K, "Bone marrow microenvironment and the identification of new targets for myeloma therapy", Leukemia, 23, pp.10~24 (2009)
- Mitsiades CS, "Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment", J Cell Biochem, 101, pp.950~968 (2007)
- Coussens LM, "Inflammation and cancer", Nature, 420, pp.860~867 (2002)
- Pollard JW, "Tumour-educated macrophages promote tumour progression and metastasis", Nat Rev Cancer, 4, pp.71~78 (2004)
- Lamagna C, "Dual role of macrophages in tumor growth and angiogenesis", J Leukoc Biol, 80, pp.705~713 (2006)
- Alvaro-Naranjo T, "Tumor-infiltrating cells as a prognostic factor in Hodgkin’s lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients", Leuk Lymphoma, 46, pp.1581~1591 (2005)
- Steidl C, "Tumor-associated macrophages and survival in classic Hodgkin’s lymphoma", N Engl J Med, 362, pp.875~885 (2010)
- Pusztaszeri MP, "Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues", J Histochem Cytochem, 54, pp.385~395 (2006)
- Farinha P, "Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)", Blood, 106, pp.2169~2174 (2005)
- Suyani E, "Tumor-associated macrophages as a prognostic parameter in multiple myeloma", Ann Hematol, 92, pp.669~677 (2013)
- Ribatti D, "Macrophages and tumor angiogenesis", Leukemia, 21, pp.2085~2089 (2007)
- Green CE, "Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization", PLoS One, 4, pp.e6713~ (2009)
- Porrata LF, "Absolute monocyte", lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma, 2012, pp.53, 2159~2165
- Wilcox RA, "The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma", Leuk Lymphoma, 53, pp.575~580 (2012)
- Porrata LF, "Peripheral blood lymphocyte", monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma, 2012, pp.97, 262~269
- Inoue H, "Overview of automated hematology analyzer XE-2100TM", Sysmex J Int, 9, pp.58~64 (1999)
- Clark TG, "Survival analysis part I: basic concepts and first analyses", Br J Cancer, 89, pp.232~238 (2003)
- Hothorn T, "On the exact distribution of maximally selected rank statistics", Comput Stat Data Anal, 43, pp.121~137 (2003)
- Boulesteix AL, "Maximally selected chi-square statistics for ordinal variables", Biom J, 48, pp.451~462 (2006)
- Song MK, "Clinical value of absolute lymphocyte counts before bortezomib-dexamethasone therapy in relapsed multiple myeloma patients", Acta Haematol, 124, pp.34~39 (2010)
- Le Jeune C, "Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia", Leuk Lymphoma (2013)
- Scavelli C, "Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma", Oncogene, 27, pp.663~674 (2008)
- Berardi S, "Multiple myeloma macrophages: pivotal players in the tumor microenvironment", J Oncol, 2013, pp.183602~ (2013)
- Vacca A, "Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma", Blood, 93, pp.3064~3073 (1999)
- Zheng Y, "Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis", Blood, 114, pp.3625~3628 (2009)
- Ben-Baruch A., "Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators", Semin Cancer Biol, 16, pp.38~52 (2006)
- Dirkx AE, "Monocyte", macrophage infiltration in tumors: modulators of angiogenesis, 2006, pp.80, 1183~1196